Foundation for Innovative New Diagnostics-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Foundation for Innovative New Diagnostics - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014016
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured project management framework, product development services, buruli ulcer diagnosis, chagas disease diagnostic solutions, hat diagnostic solutions, and tuberclosis diagnostic solutions. FIND also provides malaria therapy programs, neglected tropical diseases therapy programs, tuberculosis therapy programs, HIV therapy programs, and cross-cutting themes solutions. The organization has its presence in Switzerland, India, Uganda, and South Africa. FIND is headquartered in Geneva, Switzerland.

Foundation for Innovative New Diagnostics – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Foundation for Innovative New Diagnostics, Medical Devices Deals, 2011 to YTD 2017 9
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Janssen Pharma Enters into Agreement with Foundation for Innovative New Diagnostics 11
Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 12
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 13
Foundation for Innovative New Diagnostics – Key Competitors 14
Foundation for Innovative New Diagnostics – Key Employees 15
Foundation for Innovative New Diagnostics – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Key Facts 2
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Foundation for Innovative New Diagnostics, Deals By Therapy Area, 2011 to YTD 2017 8
Foundation for Innovative New Diagnostics, Medical Devices Deals, 2011 to YTD 2017 9
Foundation for Innovative New Diagnostics, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Janssen Pharma Enters into Agreement with Foundation for Innovative New Diagnostics 11
Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 12
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 13
Foundation for Innovative New Diagnostics, Key Competitors 14
Foundation for Innovative New Diagnostics, Key Employees 15
Foundation for Innovative New Diagnostics, Other Locations 16

★海外企業調査レポート[Foundation for Innovative New Diagnostics-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Credit Agricole CIB SA:企業の戦略的SWOT分析
    Credit Agricole CIB SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Korn Ferry (KFY):企業の財務・戦略的SWOT分析
    Korn Ferry (KFY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Aster DM Healthcare-製薬・医療分野:企業M&A・提携分析
    Summary Aster DM Healthcare (Aster DM), formerly Dr Moopens Healthcare Management Services LLC is a healthcare service provider that provides patient care services. The company offers services such as cardiac surgery, mobile medical units, village adoption, early cancer detection centers and dialysi …
  • Innate Immunotherapeutics Ltd (IIL)-製薬・医療分野:企業M&A・提携分析
    Summary Innate Immunotherapeutics Ltd (Innate Immunotherapeutics), formerly Innate Therapeutics Ltd is a medical biotechnology company that develops therapeutic drugs for the treatment of cancer and infectious diseases. The company designs and develops immunomodulator microparticle technology. Innat …
  • TVS Motor Co Ltd:戦略・SWOT・企業財務分析
    TVS Motor Co Ltd - Strategy, SWOT and Corporate Finance Report Summary TVS Motor Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • UGI Corp (UGI):企業の財務・戦略的SWOT分析
    UGI Corp (UGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • GV Gold:企業の戦略・SWOT・財務情報
    GV Gold - Strategy, SWOT and Corporate Finance Report Summary GV Gold - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Society for Worldwide Interbank Financial Telecommunication:企業の戦略的SWOT分析
    Society for Worldwide Interbank Financial Telecommunication - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, k …
  • Astex Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Astex Pharmaceuticals Inc (Astex Pharmaceuticals), is a novel drug discovery and development company with a focus on cancer and central nervous system (CNS) diseases. It discovers and develops small molecule treatments. The company’s lead product, Dacogen (indicated for the treatment of myel …
  • GLG Life Tech Corp (GLG):企業の財務・戦略的SWOT分析
    GLG Life Tech Corp (GLG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hirose Electric Co Ltd (6806):企業の財務・戦略的SWOT分析
    Hirose Electric Co Ltd (6806) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Trinity Exploration and Production plc (TRIN):石油・ガス:M&Aディール及び事業提携情報
    Summary Trinity Exploration and Production plc (Trinity), formerly Bayfield Energy Holdings plc is an oil and gas company that explores and develops onshore and offshore projects. The company’s activities include production, development, exploration and extraction of hydrocarbons. It operates in Tri …
  • Occidental Chemical Corporation:企業の戦略的SWOT分析
    Occidental Chemical Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Glow Energy Public Co Ltd:発電所・企業SWOT分析
    Glow Energy Public Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Donaldson Co Inc (DCI):企業の財務・戦略的SWOT分析
    Donaldson Co Inc (DCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Eesti Energia AS:電力:M&Aディール及び事業提携情報
    Summary Eesti Energia AS (Eesti Energia) is an international energy company. It offers energy solutions ranging from electricity, heat and fuel production to sales, customer service and ancillary energy services among others. Eesti Energia sells electricity to the Baltic retail customers and the who …
  • Innovation Pharmaceuticals Inc (IPIX):医療機器:M&Aディール及び事業提携情報
    Summary Innovation Pharmaceuticals Inc (Innovation Pharmaceuticals), formerly Cellceutix Corp, is a biopharmaceutical company that discovers and advances medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications. The company provides pipeline products such as kevetr …
  • Encore Wire Corporation:企業の戦略・SWOT・財務情報
    Encore Wire Corporation - Strategy, SWOT and Corporate Finance Report Summary Encore Wire Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • McKinsey & Company, Inc.:戦略・SWOT・企業財務分析
    McKinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary McKinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Savanna Energy Services Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Savanna Energy Services Corp (Savanna), a subsidiary of Total Energy Services Inc, is an oilfield service provider that offers drilling, well servicing and oilfield rental services. The company conducts drilling, hybrid drilling, and well servicing and oilfield services such as oilfield equi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆